Fundz

Shennon Biotechnologies Appoints Cyril Konto as Chief Executive Officer

PRIVATESep 14, 2026

Position

Chief Executive Officer

Company

Shennon Biotechnologies

Cyril Konto, M.D.
San FranciscoBiotechnology

Description

Shennon Biotechnologies has appointed Cyril Konto, M.D., as its Chief Executive Officer. This appointment comes alongside the company's recent financing round of $12M and the unveiling of its precision immunotherapy pipeline.

Quick answer

Shennon Biotechnologies Appoints Cyril Konto as Chief Executive Officer (September 14, 2026). Shennon Biotechnologies is based in San Francisco, California, United States.

What did Shennon Biotechnologies announce on September 14, 2026?
Shennon Biotechnologies has appointed Cyril Konto, M.D., as its Chief Executive Officer. This appointment comes alongside the company's recent financing round of $12M and the unveiling of its precision immunotherapy pipeline.
What does Shennon Biotechnologies do?
ShennonBio has developed a proprietary platform that can profile millions of immune cells functionally at the single cell level at unprecedented throughput and accuracy, which resolves a key bottleneck in immunotherapy.
Where is Shennon Biotechnologies based?
Shennon Biotechnologies is based in San Francisco, California, United States.
Which similar companies made leadership changes around the same time?
Vyome Holdings (September 14, 2026), Mesothelioma UK (September 14, 2026), BLOC (Biopharma Leaders of Color) (September 14, 2026) and Q32 Bio (September 14, 2026) also announced leadership changes within 45 days of Shennon Biotechnologies.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Shennon Biotechnologies, and when

A new leader at Shennon Biotechnologies brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Shennon Biotechnologies raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Shennon Biotechnologies, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Shennon Biotechnologies. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Shennon Biotechnologies

Location

953 INDIANA STREET

San Francisco, California, United States

About

ShennonBio has developed a proprietary platform that can profile millions of immune cells functionally at the single cell level at unprecedented throughput and accuracy, which resolves a key bottleneck in immunotherapy. We utilize the platform to functionally profile immune cells and their cognate antigens and apply this knowledge to develop more effective therapies against solid tumors and autoimmune diseases. Based in San Francisco next to UCSF Mission Bay, we are funded by DCVC, Foundation Capital and AV8.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Shennon Biotechnologies changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Li
Senior decision-maker at this company
••••••••@••••••••

See Li's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Shennon Biotechnologies's next move

Learn about Strategic plan

Shennon Biotechnologies changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.